CEA is evidently overexpressed in serum of patients with colon cancer, breast cancer, lung cancer, and other malignant tumors, and the decrease of its level can indicate the reduction of lung cancer tumor cells [12]. This evidence concerns the gene CEACAM5 and breast carcinoma.